NEW YORK (360Dx) – InBios announced today that it has received 510(k) clearance from the US Food and Drug Administration for an antibody-based point-of-care, rapid test that detects Chagas disease.

The firm's Chagas Detect Plus Rapid Test Kit, developed in collaboration with the Infectious Disease Research Institute in Seattle, employs an immunochromatographic strip assay to detect human IgG antibodies to Trypanosoma cruzi in human serum and whole blood matrices, including venous and capillary whole blood.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
26
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.